ENvue Medical, Inc. FEED
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -154.63% | -303.59% | -390.82% | -119.11% | -193.75% |
| Total Depreciation and Amortization | 148.95% | 5,668.42% | 89,600.00% | 63,800.00% | 38,100.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8,157.89% | 2,242.07% | 1,268.71% | -760.38% | -76.49% |
| Change in Net Operating Assets | -63.32% | -75.26% | 127.22% | 728.08% | 1,489.62% |
| Cash from Operations | -90.65% | -276.25% | -272.50% | -194.59% | -165.08% |
| Capital Expenditure | -955.56% | -928.57% | -1,900.00% | -1,133.33% | -200.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -100.00% | -100.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -168.35% | -151.06% | 3,033.33% | 3,800.00% | 4,733.33% |
| Total Debt Issued | -100.00% | -41.90% | -- | -- | -- |
| Total Debt Repaid | 51.85% | -- | -- | -- | -- |
| Issuance of Common Stock | 213.37% | 111,707.14% | 97,778.57% | 90,800.00% | 96.02% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 12.03% | 1,239.30% | 1,278,500.00% | 1,281,900.00% | 85.55% |
| Foreign Exchange rate Adjustments | 141.67% | 109.09% | 100.00% | 42.86% | 75.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -254.44% | 179.28% | 238.36% | 328.65% | -1.41% |